| Name | Title | Contact Details |
|---|
Crosbie & Company is a Toronto, ON-based company in the Financial Services sector.
The Federal Reserve Bank of Boston is one of 12 banks in the Federal Reserve System that serves as the central bank of the United States. As a leader in financial regulation, monetary policy, and a pioneer of new payment strategies the Boston Fed uses cutting edge technology to achieve its goals and ensure a vibrant economy. As part of the central bank of the United States the Fed is tasked with ensuring the growth and stability of the global economy, and is called upon to respond to financial crises. In order to do this the Federal Reserve Bank of Boston has pioneered cutting edge payment methods, developed state of the art data security programs, and conducted extensive research to assist in policy directives from the Federal Government. The Boston Federal Reserve serves the First Federal Reserve District that includes the six New England states: Connecticut (excluding Fairfield County), Massachusetts, Maine, New Hampshire, Rhode Island and Vermont. With a great and growing commitment to diversity and community outreach, the Boston Fed continues to promote sound growth and financial stability in New England and throughout the nation.
Diam USA Inc. is the US division of DIAM Co., Ltd. based in New York and manages over $3.2 billion *1 in equity, quantitative equity, fixed income and fund strategies for U.S. and Japanese institutional investors. The company was formed in 2000 and is a Registered Investment Advisor. DIAM USA Inc. changed its name from DLIBJ Asset Management USA Inc. on January 1, 2008. DIAM Group is a global investment management organization based in Tokyo that was formed in 1999 as a 50%/50% joint venture of two of the largest Japanese financial services firms -- Dai-ichi Life Insurance Company and Mizuho Financial Group (NYSE listed: MFG). The structure of the DIAM Group was created from pre-existing asset management units of Dai-ichi Life and Mizuho Financial Group.
Section 32 focus areas include biotechnology, therapeutics, advanced diagnostics, precision medicine, software, cybersecurity, machine learning, and artificial intelligence.